What is Valneva SE (VLA)?
Valneva SE is a biotechnology company specializing in the development and commercialization of vaccines for infectious diseases. Headquartered in Europe, the company focuses on vaccines that address unmet medical needs, including those for Lyme disease, chikungunya, and other pathogens. Valneva's portfolio includes both marketed vaccines and candidates in various stages of clinical development. The company employs a research-driven approach, combining traditional vaccine technologies with innovative platforms. Valneva collaborates with public health organizations, governments, and industry partners to advance vaccine accessibility and development. Its operations encompass research and development, manufacturing, and global distribution. Valneva's work contributes to public health efforts by targeting diseases with significant impact worldwide.
Valneva SE Stock Price Today: Live Overview
The price today is shaped by ongoing market activity for Valneva SE, with a current price of €4.56. The trading range so far spans from €4.43 to €4.73, showing a daily percentage change of 0%.
FAQ: Valneva SE (VLA)
What is the current price of VLA stock?
The current trading price is €4.56.
Does VLA pay dividends?
Valneva SE pays dividends via cash distributions (if applicable).
Does VLA have a formal corporate presence or regional headquarters in the UAE?
Valneva SE has a registered presence in the UAE but does not maintain an official regional office or subsidiary.
What is VLA best known for?
Valneva SE is most famous for its development of vaccines for infectious diseases.
What assets are typically shown together with VLA?
Commonly shown alongside VLA: Omeros Corp, 4D Molecular Therapeutics Inc, Catalyst Pharmaceuticals
Latest shares articles



